{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:48:25Z","timestamp":1786736905688,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jcrt.jcrt_759_19","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T05:49:12Z","timestamp":1595483352000},"page":"43","source":"Crossref","is-referenced-by-count":0,"title":["Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells"],"prefix":"10.4103","volume":"16","author":[{"given":"Hayriye","family":"Sahinli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalan","family":"Aky\u00fcrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukaddes","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olcay","family":"Kandemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015feOcak","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezer","family":"Kula\u00e7o\u01e7lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"\u00d6zet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OBerna \u00c7.","family":"\u00d6ks\u00fczo\u01e7lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NuriyeY","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.290471-1","first-page":"275","volume-title":"Nasopharyngeal cancer","author":"Chan","year":"2003","journal-title":"Cancer Treat Res"},{"key":"key-10.4103\/0973-1482.290471-2","first-page":"224","volume-title":"Nasopharyngeal carcinoma: Review of the literature with a focus on therapeutical implications","author":"Strazzulla","year":"2015","journal-title":"Infez Med"},{"key":"key-10.4103\/0973-1482.290471-3","first-page":"43627","volume-title":"PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"key-10.4103\/0973-1482.290471-4","first-page":"1311","volume-title":"Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: Current and future directions","author":"Ma","year":"2008","journal-title":"Cancer Sci"},{"key":"key-10.4103\/0973-1482.290471-5","first-page":"86","volume-title":"Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma","author":"Zhang","year":"2015","journal-title":"Med Oncol"},{"key":"key-10.4103\/0973-1482.290471-6","first-page":"1874","volume-title":"Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: Long-term results of a phase 2 study","author":"Xiao","year":"2011","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.290471-7","first-page":"310","volume-title":"Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): Evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells","author":"Khanna","year":"1998","journal-title":"Cancer Res"},{"key":"key-10.4103\/0973-1482.290471-8","first-page":"370","volume-title":"Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function","author":"Pai","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"key-10.4103\/0973-1482.290471-9","first-page":"1185","volume-title":"Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal","author":"Fife","year":"2009","journal-title":"Nat Immunol"},{"key":"key-10.4103\/0973-1482.290471-10","first-page":"29","volume-title":"The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses","author":"Carreno","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"key-10.4103\/0973-1482.290471-11","first-page":"207","volume-title":"Targeting the PD-1\/B7-H1(PD-L1) pathway to activate anti-tumor immunity","author":"Topalian","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"key-10.4103\/0973-1482.290471-12","first-page":"378","volume-title":"Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma","author":"Li","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"key-10.4103\/0973-1482.290471-13","first-page":"451","volume-title":"Clinical evaluation of compounds targeting PD-1\/PD-L1 pathway for cancer immunotherapy","author":"Lu","year":"2015","journal-title":"J Oncol Pharm Pract"},{"key":"key-10.4103\/0973-1482.290471-14","first-page":"467","volume-title":"Inhibitory B7-family molecules in the tumour microenvironment","author":"Zou","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"key-10.4103\/0973-1482.290471-15","first-page":"251","volume-title":"The new B7s: Playing a pivotal role in tumor immunity","author":"Flies","year":"2007","journal-title":"J Immunother"},{"key":"key-10.4103\/0973-1482.290471-16","first-page":"15","volume-title":"Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer","author":"Muenst","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"key-10.4103\/0973-1482.290471-17","first-page":"3381","volume-title":"Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up","author":"Thompson","year":"2006","journal-title":"Cancer Res"},{"key":"key-10.4103\/0973-1482.290471-18","first-page":"78","volume-title":"Prognostic significance of PD-L1 and PD-L2 in breast cancer","author":"Baptista","year":"2016","journal-title":"Hum Pathol"},{"key":"key-10.4103\/0973-1482.290471-19","first-page":"e0157969","volume-title":"Correlation of PD-L1 expression of tumor cells with survival outcomes after radical \u0131ntensity-modulated radiation therapy for non-metastatic nasopharyngeal carcinoma","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.290471-20","first-page":"693","volume-title":"Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","author":"Pathmanathan","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.290471-21","first-page":"677","volume-title":"PD-1 and its ligands in tolerance and immunity","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"key-10.4103\/0973-1482.290471-22","first-page":"839","volume-title":"B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells","author":"Tseng","year":"2001","journal-title":"J Exp Med"},{"key":"key-10.4103\/0973-1482.290471-23","first-page":"e1235107","volume-title":"PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome","author":"Obeid","year":"2016","journal-title":"Oncoimmunology"},{"key":"key-10.4103\/0973-1482.290471-24","first-page":"1809","volume-title":"B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function","author":"Tamura","year":"2001","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.290471-25","first-page":"17174","volume-title":"Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target","author":"Thompson","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0973-1482.290471-26","first-page":"190","volume-title":"The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: Correlation with important high-risk prognostic factors","author":"Ghebeh","year":"2006","journal-title":"Neoplasia"},{"key":"key-10.4103\/0973-1482.290471-27","first-page":"98","volume-title":"Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer","author":"Loos","year":"2008","journal-title":"Cancer Lett"},{"key":"key-10.4103\/0973-1482.290471-28","first-page":"6341","volume-title":"Tumor-expressed B7-H1 and B7-DC in relation to PD-1+T-cell infiltration and survival of patients with cervical carcinoma","author":"Karim","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0973-1482.290471-29","first-page":"5094","volume-title":"B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression","author":"Konishi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0973-1482.290471-30","first-page":"22","volume-title":"Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions","author":"Avril","year":"2010","journal-title":"J Neuroimmunol"},{"key":"key-10.4103\/0973-1482.290471-31","first-page":"2443","volume-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.290471-32","first-page":"87","volume-title":"Assays for predicting and monitoring responses to lung cancer immunotherapy","author":"Teixid\u00f3","year":"2015","journal-title":"Cancer Biol Med"},{"key":"key-10.4103\/0973-1482.290471-33","first-page":"513","volume-title":"Harnessing the PD-1 pathway in renal cell carcinoma: Current evidence and future directions","author":"Tripathi","year":"2014","journal-title":"BioDrugs"},{"key":"key-10.4103\/0973-1482.290471-34","first-page":"6993","volume-title":"A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinoma","author":"Sakane","year":"2018","journal-title":"Oncotarget"},{"key":"key-10.4103\/0973-1482.290471-35","first-page":"847","volume-title":"PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy","author":"Patel","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"key-10.4103\/0973-1482.290471-36","first-page":"54","volume-title":"PD-L1 expression in the Merkel cell carcinoma microenvironment: Association with inflammation, Merkel cell polyomavirus and overall survival","author":"Lipson","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"key-10.4103\/0973-1482.290471-37","first-page":"2233","volume-title":"Clinical impact of programmed cell death ligand 1 expression in colorectal cancer","author":"Droeser","year":"2013","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0973-1482.290471-38","first-page":"107","volume-title":"Programmed death ligand-1 expression in non-small cell lung cancer","author":"Velcheti","year":"2014","journal-title":"Lab Invest"},{"key":"key-10.4103\/0973-1482.290471-39","first-page":"127ra37","volume-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","author":"Taube","year":"2012","journal-title":"Sci Transl Med"},{"key":"key-10.4103\/0973-1482.290471-40","first-page":"5023","volume-title":"PD-L1 expression in human cancers and its association with clinical outcomes","author":"Wang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key-10.4103\/0973-1482.290471-41","first-page":"e1312240","volume-title":"Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes","author":"Zhu","year":"2017","journal-title":"Oncoimmunology"},{"key":"key-10.4103\/0973-1482.290471-42","first-page":"221","volume-title":"Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma","author":"Ritprajak","year":"2015","journal-title":"Oral Oncol"},{"key":"key-10.4103\/0973-1482.290471-43","first-page":"84","volume-title":"Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma","author":"Parsa","year":"2007","journal-title":"Nat Med"},{"key":"key-10.4103\/0973-1482.290471-44","first-page":"54","volume-title":"Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians","author":"Outh-Gauer","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"key-10.4103\/0973-1482.290471-45","first-page":"1597","volume-title":"PD-1\/PD-L1 blockade: Have we found the key to unleash the antitumor \u0131mmune response?","author":"Xu-Monette","year":"2017","journal-title":"Front Immunol"},{"key":"key-10.4103\/0973-1482.290471-46","first-page":"568","volume-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"key-10.4103\/0973-1482.290471-47","first-page":"200ra116","volume-title":"Up-regulation of PD-L1, IDO, and T (regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"key-10.4103\/0973-1482.290471-48","first-page":"3969","volume-title":"Differential expression of \u0131mmune-regulatory genes associated with PD-L1 display in melanoma: Implications for PD-1 pathway blockade","author":"Taube","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0973-1482.290471-49","doi-asserted-by":"crossref","unstructured":"Liu YJ, Tsang NM, Hsueh C, Yeh CJ, Ueng SH, Wang TH, et al. Low PD-L1 expression strongly correlates with local recurrence in Epstein\u2013Barr virus-positive nasopharyngeal carcinoma after radiation-based therapy. Cancers (Basel) 2018;10. pii: E374.","DOI":"10.3390\/cancers10100374"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:47:36Z","timestamp":1786733256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_759_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"alternative-id":["290471"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_759_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}